Press release
Investigation announced for Long-Term Investors in shares of Ardelyx, Inc. (NASDAQ: ARDX) over possible Wrongdoing
An investigation on behalf of current long term investors in Ardelyx, Inc. (NASDAQ: ARDX) shares.
Investors who are current long term investors in Ardelyx, Inc. (NASDAQ: ARDX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ARDX stocks follows a lawsuit filed against Ardelyx, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ARDX stocks, concerns whether certain Ardelyx, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of Massachusetts the plaintiff alleges that as a result of Defendants' wrongful acts and omissions, and the precipitous decline in the market value of the Company's securities, investors who purchased shares of of Ardelyx, Inc. (NASDAQ: ARDX) between October 31, 2023 and July 1, 2024 have suffered significant losses and damages.
Those who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Ardelyx, Inc. (NASDAQ: ARDX) over possible Wrongdoing here
News-ID: 3910835 • Views: …
More Releases from Shareholders Foundation, Inc.
Investors who hold shares of BioAge Labs, Inc. (NASDAQ: BIOA) Long Term should c …
An investigation was announced for current long-term investors in shares of BioAge Labs, Inc. (NASDAQ: BIOA) concerning potential breaches of fiduciary duties by certain directors of BioAge Labs, Inc.
Investors who are current long term investors in BioAge Labs, Inc. (NASDAQ: BIOA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
e.l.f. Beauty, Inc. (NYSE: ELF) Investor Notice: Deadline in Lawsuit on May 5, 2 …
A deadline is coming up on May 5, 2025 in the lawsuit filed for certain investors of e.l.f. Beauty, Inc. (NYSE: ELF).
Investors who purchased shares of e.l.f. Beauty, Inc. (NYSE: ELF) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. e.l.f. Beauty, Inc. (NYSE: ELF) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed…
Investigation announced for Long-Term Investors in Revance Therapeutics, Inc. (N …
An investigation was announced for current long-term investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning potential breaches of fiduciary duties by certain directors of Revance Therapeutics, Inc.
Investors who are current long term investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Skyworks Solutions, Inc. (NASDAQ: SWKS) Shareholder Notice: Deadline in Lawsuit …
The Shareholders Foundation announced that a deadline is coming up on May 5, 2025 in the lawsuit filed for certain investors of Skyworks Solutions, Inc. (NASDAQ: SWKS) over alleged securities laws violations by Skyworks Solutions, Inc.
Investors who purchased shares of Skyworks Solutions, Inc. (NASDAQ: SWKS) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. Skyworks Solutions, Inc. (NASDAQ: SWKS) stockholders should contact the Shareholders…
More Releases for Ardelyx
Investigation for Investors in NASDAQ: ARDX shares over possible Wrongdoing at A …
An investigation was announced for current long-term investors in shares of Ardelyx, Inc. (NASDAQ: ARDX) was announced over potential breaches of fiduciary duties by certain officers and directors at Ardelyx, Inc.
Investors who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Ardelyx, Inc. directors breached their fiduciary…
Ardelyx, Inc. (NASDAQ: ARDX) Long Term Investor Notice: Lawsuit filed against Di …
An investor in shares of Ardelyx, Inc. (NASDAQ: ARDX) filed a lawsuit against certain directors of Ardelyx, Inc over alleged breaches of fiduciary duties.
Investors who are current long term investors in Ardelyx, Inc. (NASDAQ: ARDX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges that certain directors engaged in insider trading and made false and misleading statements about…
Short Bowel Syndrome Market by Trends, Dynamic Innovation in Technology and 2027 …
Short Bowel Syndrome market research is the in-depth representation of information regarding market expansion, description, progress rate and global investigation of the market. It consists of latest methods which are proven to be more efficient for the market growth. Well-established and dynamic approaches and newly introduced technologies are also covered here. It depicts several revenue making methods adopted by industries. This Short Bowel Syndrome market study will help business players…
Investigation announced for Long-Term Investors in shares of Ardelyx, Inc. (NASD …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Ardelyx, Inc.
Investors who are current long term investors in Ardelyx, Inc. (NASDAQ: ARDX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ARDX stocks follows a lawsuit filed against Ardelyx, Inc. over alleged…
Lawsuit filed for Investors in shares of Ardelyx, Inc. (NASDAQ: ARDX)
An investor, who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX), filed a lawsuit over alleged violations of Federal Securities Laws by Ardelyx, Inc.
Investors who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and for certain investors are short and strict deadlines running. Deadline: September 28, 2021. NASDAQ: ARDX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Fremont, CA based Ardelyx, Inc., a biopharmaceutical…
Investigation announced for Investors in Ardelyx, Inc. (NASDAQ: ARDX) shares
An investigation was announced concerning potential securities laws violations by Ardelyx, Inc. in connection with certain financial statements.
Investors who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Ardelyx, Inc. regarding its business, its prospects and its operations were materially false and…
